Form 8-K - Current report:
SEC Accession No. 0001213900-23-011512
Filing Date
2023-02-14
Accepted
2023-02-14 16:13:27
Documents
16
Period of Report
2023-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea173234-8k_neuroone.htm   iXBRL 8-K 40588
2 PRESS RELEASE, DATED FEBRUARY 14, 2023 ea173234ex99-1neuroone.htm EX-99.1 63587
3 CORPORATE FACT SHEET, DATED FEBRUARY 14, 2023 ea173234ex99-2neuroone.htm EX-99.2 1624
4 GRAPHIC ex99-2_001.jpg GRAPHIC 622328
5 GRAPHIC ex99-2_002.jpg GRAPHIC 674552
  Complete submission text file 0001213900-23-011512.txt   2076251

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nmtc-20230214.xsd EX-101.SCH 3218
7 XBRL LABEL FILE nmtc-20230214_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE nmtc-20230214_pre.xml EX-101.PRE 22353
10 EXTRACTED XBRL INSTANCE DOCUMENT ea173234-8k_neuroone_htm.xml XML 3510
Mailing Address 7599 ANAGRAM DR EDEN PRAIRIE MN 55344
Business Address 7599 ANAGRAM DR EDEN PRAIRIE MN 55344 (952) 426-1383
NEUROONE MEDICAL TECHNOLOGIES Corp (Filer) CIK: 0001500198 (see all company filings)

EIN.: 270863354 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-40439 | Film No.: 23629402
SIC: 3841 Surgical & Medical Instruments & Apparatus